Not Singham Again, Bhool Bhulaiyaa 3, Kanguva, this Rs 150 crore budget film based on true story will shine during Diwali 2024, lead actors are…

Apart from Ajay Devgn vs Kartik Aaryan clash, there is one pan-India film which can also be good competition at box office during Diwali 2024.



Published: October 28, 2024 10:01 AM IST


By Onam Confidential

Not Singham Again, Bhool Bhulaiyaa 3, Kanguva, this Rs 150 crore budget film based on true story will shine during Diwali 2024, lead actors are…

Diwali 2024 is looking like a blockbuster celebration for films as some big-budget movies will be hitting the silver screens. Singham Again, Bhool Bhulaiya 3 and Kanguva are the big titles that will be released theatrically. Among this, there seems another pan-India film which may create a big blast during Diwali. The trailer of the films has received great response and is produced by superstar Kamal Hassan. Can you guess the name?

The film is pronounced Warning. Based on a book- India’s Most Fearless: True Story Modern Military Heroes, it is directed under Rajkumar Periasamy’s guidance and will be released on October 31 during Diwali.

Starring Sivakarthikeyan and Sai Pallavi in lead roles, this Pan-India film narrates real life story of Major Mukund Varadarajan, who passed away in 2014 during a counterterror operation in Jammu and Kashmir.

Made under the budget of Rs 150 crore, Amaran is releasing in Tamil, Telugu, Hindi, Malayalam and Kannada languages. It has been certified with a runtime of 2 hours and 49 minutes. Sivakarthikeyan portrays the late Indian solider Major Mukund Varadarajan, while Sai Pallavi plays his on-screen wife Indu Rebecca Varghese. The music is given by GK Prakash Kumar, and songs have been doing well on all musical platforms. Moreover, it will see Bhuvan Arora in his Tamil film debut, with Rahul Bose, Lallu, Shreekumar, Shyam Mohan, Ajaey Naga Raaman, Mir Salman and Gaurav Venkatesh in supporting roles.

With the positive response, this Pan-India film is likely to reach great heights at the box office.


Topics



Comments are closed.